Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RFX7 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | PROX1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | ZNF24 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | INSR | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | KLHL24 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
mRNA | PCDHA1 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | ZNF616 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | RUNX1T1 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
mRNA | ETV2 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |